Home » News from the Brain Interchange Development

News from the Brain Interchange Development

We continue to make progress in the development of our Brain Interchange System. We recently completed our pre-clinical testing and key development milestones.  In the next phase of development, we will further refine our technology, and enter the final stages of preparation for our First-in-Human clinical studies.

As the Brain Interchange System enters the next phase, we look forward to collaborating with our U.S. clinical partners to study this novel technology in the treatment of neurogenerative and disabling neurological conditions, disorders, and diseases with unmet or suboptimal clinical solutions.

Claus Freyinger, Chief Regulatory & Clinical Officer of CorTec, says: “We continue to make progress with our pre-clinical work. We remain convinced that the Brain Interchange System is an extremely promising technology to address unmet clinical needs in areas such as stroke rehabilitation, epilepsy, and chronic pain. ”

With our plans and milestones in mind, we will of course provide you with further information on our progress. At INS in Barcelona next month, we will be presenting more details about Brain Interchange and the evaluation kit in several scientific poster sessions.

We look forward to sharing more great news with you – make sure to follow us on LinkedIn to join us on our journey!




May 23, 2024

FDA approves Investigational Device Exemption for Early Feasibility Study for rehabilitation of stroke patients using CorTec’s Closed-Loop Brain Interchange implant system.

April 30, 2024

Bernstein-CorTec Award 2024: Call for Thesis Nominations!

March 28, 2024


February 20, 2024

Save the Date – Bernstein Special Seminar on 28th of February

February 1, 2024

Press Release: CorTec ready for next phase with Brain Interchange System

January 26, 2024

CorTec featured in “Open Access Government”: A Step Closer to Enhanced Stroke Rehabilitation

October 18, 2023

Bernstein-CorTec Award 2023

September 8, 2023

Meet us in Boston!